Skip to content
Disclosery

EXANE DERIVATIVES: GRMN position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on GRMN, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 3 GRMN shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 3 shares
    Change vs previous 13F -898 shares

    <0.01% of the 13F portfolio, value $295.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 901 shares
    Change vs previous 13F -185 shares

    0.03% of the 13F portfolio, value $106,870.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,086 shares
    Change vs previous 13F -317 shares

    0.04% of the 13F portfolio, value $147,887.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,403 shares
    Change vs previous 13F -233 shares

    0.05% of the 13F portfolio, value $218,120.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,636 shares
    Change vs previous 13F -521 shares

    0.06% of the 13F portfolio, value $243,918.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 2,157 shares
    Change vs previous 13F -927 shares

    0.09% of the 13F portfolio, value $284,416.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 3,084 shares
    Change vs previous 13F +3,076 shares

    0.11% of the 13F portfolio, value $369,051.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 8 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $759.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).